Garcia C, Goldani J, Garcia V
Serviço de Diálise e Transplante da Irmandade da Santa, Casa de Misericórdia de Porto Alegre, Rio Grande do Sul, Brazil.
Pediatr Nephrol. 1992 Jan;6(1):74-7. doi: 10.1007/BF00856843.
Renal replacement therapy (RRT) for Brazilian children with uraemia has been utilized since 1970 in the state of Rio Grande do Sul. One hundred and eighty patients receiving this therapy between 1970 and 1988 have been reviewed. The annual acceptance rate of new paediatric patients in this period increased from 0.6 to 6.5 patients per million child population. Glomerulonephritis (36.1%) and pyelonephritis including urological anomalies (31.7%) were the most frequent causes of end-stage renal disease. Outpatient hospital haemodialysis was the primary form of dialytic treatment in patients 5-15 years of age. Continuous ambulatory peritoneal dialysis was more often used in patients less than 5 years of age. The survival after 1 year on dialysis was 79.9% for children aged 5-15 years starting dialysis during the period 1985-1988. Fluid overload with congestive heart failure and infection were the main causes of death in children on dialysis. Eighty-four children received 93 grafts; only 14 (15%) were from cadaveric donors. One-year patient and graft survival of first living-related donor transplants were 92.2% and 78.5% respectively during the period 1985-1988. Infection accounted for 43.5% of deaths after transplantation. We conclude that RRT is becoming increasingly successful for children in our region but that greater emphasis upon patient compliance with all forms of RRT and upon cadaver kidney donation is needed.
自1970年以来,巴西南里奥格兰德州就开始对患有尿毒症的巴西儿童采用肾脏替代疗法(RRT)。对1970年至1988年间接受该疗法的180名患者进行了回顾。在此期间,新儿科患者的年接受率从每百万儿童人口0.6例增加到6.5例。肾小球肾炎(36.1%)和包括泌尿系统异常的肾盂肾炎(31.7%)是终末期肾病最常见的病因。门诊血液透析是5至15岁患者透析治疗的主要形式。持续性非卧床腹膜透析更多用于5岁以下患者。1985年至1988年期间开始透析的5至15岁儿童透析1年后的生存率为79.9%。液体超负荷伴充血性心力衰竭和感染是透析儿童死亡的主要原因。84名儿童接受了93次移植;只有14次(15%)来自尸体供体。1985年至1988年期间,首例活体亲属供体移植的1年患者和移植物生存率分别为92.2%和78.5%。感染占移植后死亡的43.5%。我们得出结论,在我们地区,肾脏替代疗法对儿童越来越成功,但需要更加强调患者对所有形式肾脏替代疗法的依从性以及尸体肾捐献。